Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
about
South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and RadiotherapyThe intracellular domain of CD44 promotes the fusion of macrophagesRole of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data.Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPKA novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.The Therapeutic Effects of Combination Therapy with Curcumin and Alendronate on Spine Fusion Surgery in the Ovariectomized RatsImpact of dietary aromatic amino acids on osteoclastic activityPotent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo.Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.) is dependent on extract compositionWITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning.Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.RANKL signaling and osteoclastogenesis is negatively regulated by cardamoninEvaluation of effectiveness of herbal medication in cancer care: a review study.Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice.Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese miceButein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signalingEvaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis.Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivoImmune response modulation by curcumin in a latex allergy modelPlumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signalingRosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cellsGossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis.A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiationThiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation.From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer.Toward a core nutraceutical program for cancer management.Cancer-linked targets modulated by curcuminMolecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes.Therapeutic actions of curcumin in bone disorders.Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health.Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity.Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in miceAspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cellsPotential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro.Plant-derived anticancer agents: a promising treatment for bone metastasis.Safflower seed extract inhibits osteoclast differentiation by suppression of the p38 mitogen-activated protein kinase and IκB kinase activity.Ginger hexane extract suppresses RANKL-induced osteoclast differentiation.Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.
P2860
Q26766724-45A08EB9-B49D-41F2-BD31-08FAF85E84A0Q28577304-AC5BB6CD-BD75-40DA-9C41-54BC9879C088Q30989974-611E9D68-30B2-4925-B358-11601EECEE75Q33647662-82D2D320-19F1-454A-A289-64751FD58010Q33912089-ADBAF938-8440-4FC5-8A76-25AC27D43AFEQ33919650-56B0D3EB-0A76-4582-A593-DD0F09044641Q33922119-29255904-AEAB-4E48-8249-445B7FE09A94Q34025682-4CA18864-3C19-4FE2-A3F6-C7235B51B20FQ34156447-EAA76967-644C-4CCD-B58A-ED444C636C77Q34241611-18325439-4FBE-4CF2-B26C-17391493FD9CQ34554323-7FF78AFD-27A7-4CBE-8C16-7FD90084F871Q34637209-EC431E7A-295E-403C-92CC-943AA26B26DAQ34731280-63562CBE-EF5A-4F93-A501-9C80737E383AQ34959075-6F61F474-AFE2-4448-B05A-AE4CD6E8F4D6Q35085908-C341DFC2-7A2A-4823-A49E-3F5BB87CE711Q35405562-CBAE15F2-B0E4-4EA9-AEF3-BAE8DBB3D393Q35511177-F5238D21-75B8-4CD6-BC91-6C01DE30E419Q35535372-7A9D8979-3024-4FED-AE73-7DBB9A482C5BQ35605522-0AD1E231-D848-4D07-9A89-6A8B2011140EQ35633265-142D7532-6BF7-4C8C-9291-B67AA0573547Q35751362-0857D2B5-CEBB-407B-B963-A324734387BEQ35803432-4DA73054-9866-4C62-B8D7-337C6996BD76Q35839884-D4DCE9E1-AB65-4B31-8F93-C4D6937EC051Q36012065-0AA04FDB-A8CA-4EF8-8B85-8C754D3735C7Q36147288-FF745D26-DDAA-4187-BC1C-CCF59B2C1227Q36303922-93228984-F14B-4DEC-B38C-4B863A6EA9FAQ36379379-98DB8736-40F7-4629-94D1-02ED5FDC1A5AQ36473648-0929959E-9CE1-4B82-9276-EA3088A6C56CQ36499048-24207CF6-CE47-4512-845A-F1D9C4278FE2Q36517710-F6DD3157-D96E-4E2B-9FD9-CECC9379CE12Q36639210-10B02F75-1926-442A-83C6-A58D04FF68E0Q36654253-5013925A-E099-49E4-8A4E-9F230125E93EQ36755382-B6D48E7D-4F03-4573-AABB-0C4C8504E6A2Q37138897-03F94DEE-514B-4B0B-849E-BD0C5FDC61B8Q37191026-CADDABE5-7B51-4699-9BDE-BBF562822539Q37525394-8AA5E617-73D6-416D-926F-26648D8360ACQ37640924-6E589B97-95D9-46A3-8DA2-11C27335B615Q38464748-B0FBF553-A4E0-4EA3-AB76-F9B5D3A931CDQ38787084-B2856805-867B-4F33-936E-35875375E219Q38800946-B70C2B11-7E58-4174-8472-885C63642529
P2860
Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Curcumin (diferuloylmethane) i ...... suppresses osteoclastogenesis.
@en
type
label
Curcumin (diferuloylmethane) i ...... suppresses osteoclastogenesis.
@en
prefLabel
Curcumin (diferuloylmethane) i ...... suppresses osteoclastogenesis.
@en
P2093
P1476
Curcumin (diferuloylmethane) i ...... suppresses osteoclastogenesis.
@en
P2093
Alok C Bharti
Bharat B Aggarwal
Yasunari Takada
P304
P356
10.4049/JIMMUNOL.172.10.5940
P407
P577
2004-05-01T00:00:00Z